Hefei Cubic Pharmaceutical

Hefei Cubic Pharmaceutical is a China-based integrated pharmaceutical enterprise specializing in the research, development, production, and distribution of pharmaceutical products. The company is particularly recognized for its expertise in advanced drug delivery systems, specifically osmotic pump controlled-release and sustained-release technologies. Its commercial portfolio includes treatments for cardiovascular diseases, digestive system disorders, and ophthalmic conditions, with flagship products like Nifedipine sustained-release tablets. Beyond manufacturing, the company operates a comprehensive pharmaceutical distribution network within China. Hefei Cubic Pharmaceutical is listed on the Shenzhen Stock Exchange and continues to expand its pipeline in both generic and innovative drug categories.